Literature DB >> 7554020

Changes in the resistance of Plasmodium falciparum to chloroquine in Hainan, China.

D Q Liu1, R J Liu, D X Ren, D Q Gao, C Y Zhang, C P Qui, X Z Cai, C F Ling, A H Song, X Tang.   

Abstract

In 1979, in view of the widespread resistance of Plasmodium falciparum to chloroquine in the island of Hainan, China, it use as an antimalarial was suspended throughout the island. A longitudinal survey of the chloroquine-sensitivity of P. falciparum was carried out over the period 1981-91 to investigate whether its resistance had changed from the 1979 level. In-vitro assays were carried out every 2-3 years, while in-vivo tests were performed annually over the period 1981-83 and also in 1991. Resistance to chloroquine declined progressively after its use had stopped. The in-vitro tests indicated that the rate of chloroquine-resistant P. falciparum was 97.9% in 1981, but dropped to 60.9% in 1991 (P < 0.001). The mean concentration of chloroquine for complete inhibition of schizont formation was 10.4 pmol/microliters in 1981, but decreased to 3.0 pmol/microliters in 1991 (P < 0.001). The proportion of samples taken from malaria cases that required high concentrations ( > 6.4 pmol/microliters) of chloroquine for complete inhibition of schizont formation was 83.3% in 1981, but only 17.4% in 1991 (P < 0.001); at low concentrations ( > 1.6 pmol/microliters), the corresponding proportions increased from 4.2% in 1981 to 60.8% in 1991 (P < 0.001). In the 4-week in-vivo test, the rate of chloroquine-resistant P. falciparum decreased from 84.2% in 1981 to 40% in 1991 (P < 0.001). RII + RIII cases represented 59.4% of the total resistant cases in 1981, but decreased to 37.5% in 1991 (0.02 > P > 0.01).

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7554020      PMCID: PMC2486789     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  5 in total

Review 1.  Drug-resistant malaria: mechanisms of development and inferences for malaria control.

Authors:  A Björkman; P A Phillips-Howard
Journal:  Trans R Soc Trop Med Hyg       Date:  1990 May-Jun       Impact factor: 2.184

2.  Plasmodium falciparum in culture: use of outdated erthrocytes and description of the candle jar method.

Authors:  J B Jensen; W Trager
Journal:  J Parasitol       Date:  1977-10       Impact factor: 1.276

3.  [A successive survey on the sensitivity of P. falciparum patients to chloroquine by in vitro microtechnic and in vivo test on Hainan Island].

Authors:  Q L Huang
Journal:  Zhonghua Yu Fang Yi Xue Za Zhi       Date:  1985-07

4.  Drug sensitivity of plasmodium falciparum. An in-vitro microtechnique.

Authors:  K H Rieckmann; G H Campbell; L J Sax; J E Mrema
Journal:  Lancet       Date:  1978-01-07       Impact factor: 79.321

5.  Spread of chloroquine resistance in Plasmodium falciparum.

Authors:  D Payne
Journal:  Parasitol Today       Date:  1987-08
  5 in total
  19 in total

1.  Superinfection and the evolution of resistance to antimalarial drugs.

Authors:  Eili Y Klein; David L Smith; Ramanan Laxminarayan; Simon Levin
Journal:  Proc Biol Sci       Date:  2012-07-11       Impact factor: 5.349

Review 2.  Triple Combination Therapy and Drug Cycling-Tangential Strategies for Countering Artemisinin Resistance.

Authors:  Bhattacharjee Dipanjan; G Shivaprakash; O Balaji
Journal:  Curr Infect Dis Rep       Date:  2017-07       Impact factor: 3.725

3.  Apparent bias for P. falciparum parasites carrying the wild-type pfcrt allele in the placenta.

Authors:  Nadja Oster; Petra Rohrbach; Cecilia P Sanchez; Katharine T Andrews; Judith Kammer; Boubacar Coulibaly; Gabriele Stieglbauer; Heiko Becher; Michael Lanzer
Journal:  Parasitol Res       Date:  2010-02-11       Impact factor: 2.289

4.  Molecular surveillance as monitoring tool for drug-resistant Plasmodium falciparum in Suriname.

Authors:  Malti R Adhin; Mergiory Labadie-Bracho; Gustavo Bretas
Journal:  Am J Trop Med Hyg       Date:  2013-07-08       Impact factor: 2.345

5.  Mutations in cytochrome b resulting in atovaquone resistance are associated with loss of fitness in Plasmodium falciparum.

Authors:  Jennifer M Peters; Nanhua Chen; Michelle Gatton; Michael Korsinczky; Elizabeth V Fowler; Sergio Manzetti; Allan Saul; Qin Cheng
Journal:  Antimicrob Agents Chemother       Date:  2002-08       Impact factor: 5.191

6.  Monitoring Plasmodium falciparum chloroquine resistance in Yunnan Province, China, 1981-2006.

Authors:  Henglin Yang; Yaming Yang; Pinfang Yang; Xingliang Li; Baihe Gao; Zhiyong Zhang; Zhaoqing Yang; Liwang Cui
Journal:  Acta Trop       Date:  2008-09-06       Impact factor: 3.112

7.  In vitro monitoring of Plasmodium falciparum drug resistance in French Guiana: a synopsis of continuous assessment from 1994 to 2005.

Authors:  Eric Legrand; Béatrice Volney; Jean-Baptiste Meynard; Odile Mercereau-Puijalon; Philippe Esterre
Journal:  Antimicrob Agents Chemother       Date:  2007-10-22       Impact factor: 5.191

8.  No genetic bottleneck in Plasmodium falciparum wild-type Pfcrt alleles reemerging in Hainan Island, China, following high-level chloroquine resistance.

Authors:  Nanhua Chen; Qi Gao; Shanqing Wang; Guangze Wang; Michelle Gatton; Qin Cheng
Journal:  Antimicrob Agents Chemother       Date:  2007-10-22       Impact factor: 5.191

Review 9.  Antimalarial drug resistance: a review of the biology and strategies to delay emergence and spread.

Authors:  E Y Klein
Journal:  Int J Antimicrob Agents       Date:  2013-02-08       Impact factor: 5.283

10.  Molecular epidemiology of drug resistance markers of Plasmodium falciparum in Yunnan Province, China.

Authors:  Fang Huang; Linhua Tang; Henglin Yang; Shuisen Zhou; Hui Liu; Junwei Li; Shaohua Guo
Journal:  Malar J       Date:  2012-07-28       Impact factor: 2.979

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.